Advertisement

Axillary Reverse Mapping (ARM): A New Concept to Identify and Enhance Lymphatic Preservation

  • Margaret Thompson
  • Soheila Korourian
  • Ronda Henry-Tillman
  • Laura Adkins
  • Sheilah Mumford
  • Kent C. Westbrook
  • V Suzanne KlimbergEmail author
Breast Oncology

Abstract

Background

Variations in arm lymphatic drainage put the arm lymphatics at risk for disruption during axillary lymph node surgery. Mapping the drainage of the arm with blue dye (axillary reverse mapping, ARM) decreases the likelihood of disruption of lymphatics and subsequent lymphedema.

Methods

This institutional review board (IRB)-approved study from May to October 2006 involved patients undergoing SLNB and/or ALND. Technetium sulfur colloid (4 mL) was injected in the subareolar plexus and 2–5 mL of blue dye intradermally was injected in the ipsilateral upper extremity (ARM). Data were collected on variations in lymphatic drainage that impacted SLNB or ALND, successful identification and protection of the arm lymphatics, any crossover between a hot breast node and a blue arm node, and occurrence of lymphedema.

Results

Of the 40 patients undergoing surgery for breast cancer, 18 required an ALND, with a median age of 49.7 years old. Fourteen patients had a SLNB + ALND, and four patients had ALND alone. In 100% of patients, all breast SLNs were hot but not blue, and the false negative rate was 0. In 11 of 18 ALNDs (61%) blue lymphatics or blue nodes were identified in the axilla. In the initial seven cases with positive lymph nodes in the axilla, the blue node draining from the arm was biopsied and all were negative.

Conclusions

ARM identified significant lymphatic variations draining the upper extremities and facilitated preservation in all but one case. ARM added to present-day ALND and SLNB further defines the axilla and may be useful to prevent lymphedema.

Keywords

SLNB ALND Lymphedema 

References

  1. 1.
    Ivens D, et al. Assessment of morbidity from complete axillary dissection. Br J Cancer 1997; 66:136Google Scholar
  2. 2.
    Temple LK, Baron R, Cody HS 3rd, et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 2002; 9(7):654–62PubMedGoogle Scholar
  3. 3.
    Somers RG, et al. The use of closed suction drainage after lumpectomy and axillary node dissection for breast cancer; a prospective randomized trial. Ann Surg 1992; 215:146PubMedCrossRefGoogle Scholar
  4. 4.
    Schrenk P, Rieger R, Shamiyeh A, et al. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000; 88:608–14PubMedCrossRefGoogle Scholar
  5. 5.
    Haid A, Koberle-Wuhrer R, Knauer M, Burtscher J, Fritzsche H, Peschina W, Jasarevic Z, Ammann M, Hergan K, Sturn H, Zimmermann G. Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 2002; 73(1):31–6PubMedCrossRefGoogle Scholar
  6. 6.
    Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 2002; 9(8):745–53PubMedCrossRefGoogle Scholar
  7. 7.
    Blanchard DK, Donohue JH, Reynolds C, et al. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2003; 138:482–8PubMedCrossRefGoogle Scholar
  8. 8.
    Schijven MP, Vingerhoets AJ, Rutten HJ, et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003; 29:341–50PubMedCrossRefGoogle Scholar
  9. 9.
    Ronka R, von Smitten K, Tasmuth, et al. One-year morbidity after sentinel node biopsy and breast surgery. Breast 2005; 14:28–36Google Scholar
  10. 10.
    Leidenius M, Leivonen M, Vironen J, von Smitten K. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol 2005; 92(1):23–31PubMedCrossRefGoogle Scholar
  11. 11.
    Mansel R, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial: JNCI 2006; 98(9):599–609PubMedGoogle Scholar
  12. 12.
    Passik SD, McDonald MV. Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinoma. Cancer 1998; 83:2817–20PubMedCrossRefGoogle Scholar
  13. 13.
    Tobin MB, Lacey HJ, Meyer L, Mortimer PS. The psychosocial morbidity of breast cancer-related arm swelling. Psychological morbidity of lymphoedema. Cancer 1993; 72:3248–52PubMedCrossRefGoogle Scholar
  14. 14.
    Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 2001; 92(4):748–52PubMedCrossRefGoogle Scholar
  15. 15.
    Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 2006; 13(4):491–500PubMedCrossRefGoogle Scholar
  16. 16.
    Layeeque R, Kepple J, Henry-Tillman RS, Adkins L, Kass R, Colvert M, Gibson R, Mancino A, Korourian S, Klimberg VS. Intraoperative subareolar radioisotope injection for immediate sentinel lymph node biopsy. Ann Surg 2004; 239(6):841–5; discussion 845–8PubMedCrossRefGoogle Scholar
  17. 17.
    Descriptive Statistics. www.physics.csbsju.edu/stats/cstats NROW_form. HtmlGoogle Scholar
  18. 18.
    Fisher B, Slack NH. Number of lymph nodes examined and the prognosis of breast carcinoma. Surg Gynecol Obstet 1970; 131:79PubMedGoogle Scholar
  19. 19.
    Fisher B, Fisher ER, Redmond C. Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of Lphenylalanine mustard (L-PAM) in the management of primary breast cancer. J Clin Oncol 1986; 4:929PubMedGoogle Scholar
  20. 20.
    Giuliano A, Schwartz G. Summary of the proceedings of the Philadelphia Consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast. Semin Breast Dis 2002; 5:110Google Scholar
  21. 21.
    Noguchi M, Taniya T, Ohta N, et al. Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast. Breast Cancer Res Treat 1991; 19(1):23–31PubMedCrossRefGoogle Scholar
  22. 22.
  23. 23.
  24. 24.
    Bland K, Copeland E. The Breast: Comprehensive Management of Benign and Malignant Disorders, 3rd ed. St. Louis: Saunders, 2004Google Scholar
  25. 25.
    Kissin MW, della Rovere QG, Easton D, Westbury G. Risk of lymphedema following the treatment of breast cancer. Br J Surg 1986; 73:580–4PubMedCrossRefGoogle Scholar
  26. 26.
    Delouche G, Bachelot F, Premont M, Kurtz JM. Conservation treatment of early breast cancer: long term results and complications. Int J Radiat Oncol Biol Phys 1987; 13:29–34PubMedGoogle Scholar
  27. 27.
    Larson D, Weinstein M, Goldberg I, et al. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 1986; 12:1575–82PubMedGoogle Scholar
  28. 28.
    Petrek JA, Senie RT, Peters M, et al. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 2001; 92:1368–77PubMedCrossRefGoogle Scholar
  29. 29.
    Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema. Am J Surg 1999; 177:184–7PubMedCrossRefGoogle Scholar
  30. 30.
    Kwan W, Jackson J, Weir LM, et al. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol 2002; 20:4242–8PubMedCrossRefGoogle Scholar
  31. 31.
    Silberman AW, McVay C, Cohen JS, et al. Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer. Ann Surg 2004; 240:1–6PubMedCrossRefGoogle Scholar
  32. 32.
    Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 2001; 92:748–52PubMedCrossRefGoogle Scholar
  33. 33.
    Britton TM, Buczacki SJ, Turner CL, et al. Venous changes and lymphedema 4 years after axillary surgery for breast cancer. Br J Surg 2007; Epub Mar 2007Google Scholar
  34. 34.
    Soran A, D’Angelo G, Begovic M, et al. Breast cancer-related lymphedema—what are the significant predictors and how they affect the severity of lymphedema. Breast J 2006; 12(6):536–43PubMedCrossRefGoogle Scholar
  35. 35.
    McMasters KM, Giuliano AE, Ross MI, Reintgen DS, Hunt KK, Byrd DR, Klimberg VS, Whitworth PW, Tafra LC, Edwards MJ. Sentinel Lymph Node Biopsy for Breast Cancer—Not Yet the Standard of Care. N Engl J Med. 1998; 339:990–995PubMedCrossRefGoogle Scholar
  36. 36.
    Leidenius M, Leppanen E, Krogerus L, et al. Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg 2003; 185:127–30PubMedCrossRefGoogle Scholar
  37. 37.
    Burak WE, Hollenbeck ST, Zervos EE, et al. Sentinel lymph node biopsy results in less post operative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 2002; 183:23–7PubMedCrossRefGoogle Scholar
  38. 38.
    Rubio IT, Korourian S, Colvert M, Westbrook KC, Klimberg VS. Sentinel Lymph Node Biopsy for the Staging of Breast Cancer. Am J Surg 1998; 176(6):532–7PubMedCrossRefGoogle Scholar
  39. 39.
    Sakorafas GH, Peros G, Cataliotti L, et al. Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 2006; 15(3):153–65PubMedCrossRefGoogle Scholar
  40. 40.
    Uren RF, Howman-Giles R, Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med 2003; 44(4):570–82PubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2007

Authors and Affiliations

  • Margaret Thompson
    • 1
  • Soheila Korourian
    • 2
  • Ronda Henry-Tillman
    • 1
  • Laura Adkins
    • 1
  • Sheilah Mumford
    • 1
  • Kent C. Westbrook
    • 1
  • V Suzanne Klimberg
    • 1
    • 2
    Email author
  1. 1.Division of Breast Surgical Oncology, Department of SurgeryUniversity of Arkansas for Medical SciencesLittle RockUSA
  2. 2.Department of PathologyUniversity of Arkansas for Medical SciencesLittle RockUSA

Personalised recommendations